NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE

NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE was reported 1093 times

NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UVEITIS-GLAUCOMA-HYPHAEMA SYNDROME 5 0.2000
1 HETEROGENEOUSLY DENSE BREASTS 1 0.1250
2 BLEPHARORRHAPHY 1 0.0625
3 CONJUNCTIVAL RETRACTION 1 0.0625
4 BILIARY HAMARTOMA 1 0.0526
5 DISORDER OF GLOBE 2 0.0488
6 FOVEAL DEGENERATION 1 0.0435
7 CORNEAL GRAFT FAILURE 1 0.0435
8 GIANT PAPILLARY CONJUNCTIVITIS 2 0.0400
9 CORNEAL THINNING 10 0.0389
10 NEUROTROPHIC KERATOPATHY 2 0.0370
11 DEAFNESS PERMANENT 7 0.0357
12 EXPOSURE KERATITIS 1 0.0333
13 CENTRAL VISION LOSS 7 0.0314
14 CORNEAL ENDOTHELIAL CELL LOSS 2 0.0294
15 SCLEROMALACIA 2 0.0290
16 CORNEAL EPITHELIUM DISORDER 1 0.0286
17 DIABETIC GLAUCOMA 1 0.0278
18 RETINAL PIGMENT EPITHELIOPATHY 12 0.0278
19 CAROTID ARTERY BYPASS 1 0.0278
20 ANOPHTHALMOS 1 0.0270
21 ACANTHAMOEBA KERATITIS 1 0.0270
22 ACQUIRED CORNEAL DYSTROPHY 1 0.0263
23 PERSISTENT CORNEAL EPITHELIAL DEFECT 3 0.0254
24 MIXED DEAFNESS 2 0.0253
25 CHORIORETINAL ATROPHY 5 0.0243
26 OCULAR PEMPHIGOID 3 0.0240
27 ENCHONDROMATOSIS 2 0.0233
28 SEPTIC ARTHRITIS STAPHYLOCOCCAL 8 0.0230
29 BLEBITIS 1 0.0227
30 INFECTIVE SCLERITIS 2 0.0222
31 CHOROIDAL DYSTROPHY 1 0.0208
32 PUNCTATE KERATITIS 17 0.0185
33 GENITAL INFECTION MALE 1 0.0175
34 CORNEAL ULCER 1 0.0172
35 FOREIGN BODY IN EAR 1 0.0172
36 DACRYOCANALICULITIS 2 0.0169
37 EXPOSURE VIA MUCOSA 1 0.0167
38 CORNEAL LEUKOMA 1 0.0167
39 CONJUNCTIVAL EROSION 2 0.0165
40 DENTAL PARAESTHESIA 1 0.0164
41 ENDOCRINE OPHTHALMOPATHY 14 0.0161
42 IRIS TRANSILLUMINATION DEFECT 3 0.0160
43 CORNEAL SCAR 8 0.0159
44 CORNEAL PERFORATION 10 0.0158
45 ANISOMETROPIA 1 0.0154
46 CORNEAL DEFECT 2 0.0152
47 RETINOGRAM ABNORMAL 4 0.0149
48 SWEATING FEVER 2 0.0144
49 CORNEAL DYSTROPHY 6 0.0144
50 DERMATOCHALASIS 2 0.0136
51 DEVICE TEMPERATURE ISSUE 1 0.0133
52 AUTOPHONY 1 0.0133
53 DACRYOCYSTITIS 2 0.0130
54 NONINFECTIVE SIALOADENITIS 2 0.0126
55 ULCERATIVE KERATITIS 32 0.0117
56 EYELID EROSION 1 0.0115
57 FLAT ANTERIOR CHAMBER OF EYE 2 0.0112
58 MEIBOMIAN GLAND DYSFUNCTION 5 0.0110
59 CORNEAL OPERATION 1 0.0097
60 CORNEAL ABRASION 13 0.0095
61 CORNEAL ABSCESS 1 0.0093
62 OSTEORADIONECROSIS 2 0.0090
63 VERY LOW DENSITY LIPOPROTEIN INCREASED 2 0.0090
64 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
65 MACULAR FIBROSIS 6 0.0088
66 HYPOGONADISM MALE 2 0.0086
67 CORNEAL EPITHELIUM DEFECT 5 0.0086
68 CELLULITIS ORBITAL 5 0.0086
69 BILIRUBIN URINE PRESENT 1 0.0084
70 ANTERIOR CHAMBER INFLAMMATION 5 0.0084
71 ANTERIOR CHAMBER FIBRIN 1 0.0078
72 MORAXELLA INFECTION 2 0.0073
73 EPIRETINAL MEMBRANE 2 0.0072
74 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 3 0.0070
75 COLLATERAL CIRCULATION 1 0.0069
76 CORNEAL DISORDER 15 0.0068
77 CATARACT CORTICAL 1 0.0067
78 IMPAIRED FASTING GLUCOSE 2 0.0066
79 TOXIC ANTERIOR SEGMENT SYNDROME 7 0.0064
80 EYE DEGENERATIVE DISORDER 1 0.0060
81 CATARACT NUCLEAR 4 0.0060
82 VITREOUS OPACITIES 5 0.0059
83 BONE ATROPHY 1 0.0059
84 IRIS ADHESIONS 3 0.0058
85 CONJUNCTIVITIS BACTERIAL 2 0.0058
86 TONGUE PRURITUS 5 0.0058
87 CORNEAL EROSION 3 0.0056
88 CERUMEN IMPACTION 5 0.0055
89 BORDERLINE GLAUCOMA 1 0.0054
90 NOSE DEFORMITY 2 0.0054
91 NASAL TURBINATE HYPERTROPHY 2 0.0053
92 EYE INFECTION FUNGAL 2 0.0052
93 LAGOPHTHALMOS 2 0.0049
94 NASAL CRUSTING 3 0.0046
95 MUSCULAR DYSTROPHY 2 0.0046
96 EYELASH DISCOLOURATION 1 0.0046
97 PHARYNGEAL HYPOAESTHESIA 4 0.0043
98 CRANIOFACIAL DEFORMITY 1 0.0043
99 KERATIC PRECIPITATES 2 0.0042
100 CORNEAL DEGENERATION 1 0.0041
101 GENITAL DISORDER FEMALE 1 0.0041
102 CALCIUM IONISED DECREASED 1 0.0041
103 DEAFNESS NEUROSENSORY 13 0.0039
104 KERATITIS 12 0.0039
105 RETINAL INJURY 3 0.0039
106 DACRYOSTENOSIS ACQUIRED 5 0.0039
107 CORNEAL TRANSPLANT 3 0.0038
108 HYPHAEMA 2 0.0038
109 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
110 CONJUNCTIVITIS VIRAL 1 0.0038
111 BACTERIAL ENDOPHTHALMITIS 1 0.0038
112 EYELID OPERATION 1 0.0037
113 INTERTRIGO 2 0.0037
114 SUPERFICIAL INJURY OF EYE 4 0.0037
115 CHEMICAL BURNS OF EYE 1 0.0036
116 ECZEMA EYELIDS 2 0.0036
117 DERMAL ABSORPTION IMPAIRED 1 0.0036
118 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
119 SOFT TISSUE SWELLING 2 0.0035
120 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
121 EYELID PAIN 7 0.0034
122 OTORRHOEA 6 0.0034
123 GRUNTING 2 0.0033
124 BUTTOCK INJURY 1 0.0033
125 OPEN ANGLE GLAUCOMA 2 0.0033
126 KERATOPATHY 5 0.0032
127 DEVICE PROGRAMMING ERROR 1 0.0032
128 FOREIGN BODY IN EYE 3 0.0031
129 CHALAZION 2 0.0031
130 EYE INFECTION VIRAL 1 0.0031
131 CONDUCTIVE DEAFNESS 1 0.0031
132 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
133 EYELID DISORDER 7 0.0030
134 ENDOPHTHALMITIS 18 0.0030
135 MAMMOGRAM ABNORMAL 2 0.0030
136 BENIGN NEOPLASM OF SKIN 1 0.0030
137 ECTROPION 1 0.0030
138 CONJUNCTIVAL OEDEMA 3 0.0029
139 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
140 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
141 ANTERIOR CHAMBER CELL 2 0.0028
142 COLOUR BLINDNESS ACQUIRED 1 0.0028
143 INTRAOCULAR PRESSURE INCREASED 35 0.0027
144 MYCOBACTERIUM CHELONAE INFECTION 2 0.0027
145 CORNEAL DEPOSITS 2 0.0027
146 CORNEAL OEDEMA 6 0.0027
147 FOREIGN BODY SENSATION IN EYES 17 0.0027
148 HERPES SIMPLEX REACTIVATION 1 0.0026
149 PRESCRIPTION FORM TAMPERING 2 0.0026
150 KETONURIA 2 0.0025
151 ANGLE CLOSURE GLAUCOMA 6 0.0023
152 ACUTE SINUSITIS 4 0.0023
153 EYELID INFECTION 1 0.0023
154 PHYSICAL DISABILITY 10 0.0023
155 ANTI-THYROID ANTIBODY POSITIVE 1 0.0022
156 MUSCLE SWELLING 2 0.0022
157 PUPILLARY REFLEX IMPAIRED 4 0.0022
158 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
159 MASTOIDITIS 2 0.0020
160 ARTERIOVENOUS FISTULA 1 0.0020
161 CONJUNCTIVITIS ALLERGIC 3 0.0020
162 DERMATITIS INFECTED 1 0.0020
163 EAR HAEMORRHAGE 4 0.0020
164 DIABETIC RETINAL OEDEMA 1 0.0020
165 APPLICATION SITE INFECTION 1 0.0020
166 EYE ALLERGY 3 0.0019
167 EAR SWELLING 4 0.0019
168 NIGHT BLINDNESS 3 0.0019
169 BODY FAT DISORDER 1 0.0018
170 VITREOUS DETACHMENT 4 0.0018
171 EPIGLOTTITIS 1 0.0018
172 OCULAR TOXICITY 2 0.0018
173 EYE INFECTION BACTERIAL 1 0.0018
174 BONE FRAGMENTATION 1 0.0018
175 HALO VISION 2 0.0018
176 BLEPHARITIS 7 0.0017
177 EYELID MARGIN CRUSTING 5 0.0017
178 OPTIC NERVE INJURY 2 0.0017
179 GRAFT COMPLICATION 1 0.0017
180 EYE BURNS 1 0.0017
181 INSTILLATION SITE IRRITATION 2 0.0017
182 DERMATILLOMANIA 1 0.0017
183 ERYTHEMA OF EYELID 9 0.0017
184 EYE INJURY 5 0.0016
185 CATARACT SUBCAPSULAR 1 0.0016
186 ESSENTIAL HYPERTENSION 3 0.0016
187 EYE PAIN 92 0.0016
188 RETINAL TEAR 4 0.0016
189 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
190 MACULAR OEDEMA 9 0.0016
191 DERMATOSIS 1 0.0016
192 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
193 EYE INFLAMMATION 15 0.0016
194 RETINAL OEDEMA 3 0.0016
195 OCULAR HYPERTENSION 3 0.0015
196 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
197 STOMA SITE INFECTION 2 0.0015
198 HERPES OPHTHALMIC 2 0.0015
199 EPISCLERITIS 1 0.0014
200 EYE DISCHARGE 15 0.0014
201 CONTRAINDICATED DRUG ADMINISTERED 1 0.0014
202 CULTURE URINE POSITIVE 2 0.0014
203 JAUNDICE CHOLESTATIC 5 0.0014
204 CERVICAL RADICULOPATHY 1 0.0014
205 EYE IRRITATION 80 0.0014
206 ACCOMMODATION DISORDER 1 0.0014
207 FIBROCYSTIC BREAST DISEASE 1 0.0014
208 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
209 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
210 EAR DISCOMFORT 13 0.0013
211 OCULAR HYPERAEMIA 60 0.0013
212 NASAL ULCER 2 0.0013
213 OCULAR DISCOMFORT 14 0.0012
214 ENDOMETRIAL HYPERPLASIA 1 0.0012
215 BREAST OPERATION 1 0.0012
216 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
217 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
218 SEBORRHOEIC DERMATITIS 2 0.0012
219 CAMPYLOBACTER INFECTION 1 0.0012
220 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
221 EYELID IRRITATION 3 0.0012
222 GINGIVAL ERYTHEMA 1 0.0012
223 ENCEPHALITIS 8 0.0012
224 HORDEOLUM 5 0.0012
225 GENITAL BURNING SENSATION 1 0.0012
226 PUPIL FIXED 2 0.0012
227 VERTIGO POSITIONAL 2 0.0011
228 SKIN HYPOPIGMENTATION 2 0.0011
229 SWELLING OF EYELID 7 0.0011
230 OPHTHALMIC HERPES ZOSTER 2 0.0011
231 ANAEMIA OF CHRONIC DISEASE 1 0.0011
232 LACRIMATION INCREASED 33 0.0011
233 BONE CONTUSION 1 0.0011
234 VITREOUS HAEMORRHAGE 3 0.0011
235 ABULIA 1 0.0011
236 VITRITIS 2 0.0011
237 EYE INFECTION 12 0.0011
238 CYSTOID MACULAR OEDEMA 2 0.0011
239 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
240 FACE INJURY 4 0.0011
241 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
242 EYELID RASH 1 0.0010
243 STRABISMUS 3 0.0010
244 GROWTH RETARDATION 3 0.0010
245 JOINT NOISE 2 0.0010
246 UNDERWEIGHT 2 0.0010
247 PHOTOPHOBIA 19 0.0010
248 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
249 AUTONOMIC NEUROPATHY 1 0.0010
250 BREAST ABSCESS 1 0.0010
251 OSTEOLYSIS 2 0.0010
252 HYPERPARATHYROIDISM 2 0.0010
253 ACUTE CORONARY SYNDROME 8 0.0010
254 AXILLARY MASS 1 0.0010
255 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
256 UVEITIS 13 0.0010
257 LIVEDO RETICULARIS 2 0.0010
258 ENTEROCOCCAL BACTERAEMIA 1 0.0009
259 TONGUE DISCOMFORT 4 0.0009
260 VISUAL ACUITY REDUCED 31 0.0009
261 GALLBLADDER ENLARGEMENT 1 0.0009
262 CLAUSTROPHOBIA 1 0.0009
263 OTITIS MEDIA 3 0.0009
264 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
265 AORTIC DILATATION 1 0.0009
266 COMPLEX PARTIAL SEIZURES 1 0.0009
267 HEPATIC CYST 3 0.0009
268 EYELID OEDEMA 10 0.0009
269 DILATATION ATRIAL 1 0.0009
270 DEVICE DISPENSING ERROR 1 0.0008
271 CONJUNCTIVAL HYPERAEMIA 3 0.0008
272 COCCIDIOIDOMYCOSIS 1 0.0008
273 DYSPLASIA 1 0.0008
274 EYELID SKIN DRYNESS 1 0.0008
275 TRANSPLANT FAILURE 2 0.0008
276 EYE SWELLING 30 0.0008
277 HYPERPARATHYROIDISM SECONDARY 2 0.0008
278 FISTULA DISCHARGE 1 0.0008
279 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
280 INCREASED BRONCHIAL SECRETION 2 0.0008
281 BLOOD BILIRUBIN ABNORMAL 1 0.0008
282 MEAN CELL VOLUME INCREASED 2 0.0008
283 AORTIC ARTERIOSCLEROSIS 2 0.0008
284 MENOPAUSE 2 0.0008
285 EYE PRURITUS 26 0.0008
286 ABDOMINAL OPERATION 1 0.0008
287 RETINAL DISORDER 2 0.0008
288 IMPAIRED QUALITY OF LIFE 11 0.0008
289 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
290 BRUXISM 4 0.0007
291 BLOOD SODIUM INCREASED 2 0.0007
292 VITAMIN B12 DEFICIENCY 3 0.0007
293 BODY MASS INDEX INCREASED 1 0.0007
294 EAR CONGESTION 2 0.0007
295 CARBON DIOXIDE INCREASED 1 0.0007
296 CORNEAL OPACITY 1 0.0007
297 STOMA SITE DISCHARGE 2 0.0007
298 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
299 ECHOCARDIOGRAM ABNORMAL 1 0.0007
300 SKIN HYPERTROPHY 2 0.0007
301 BLINDNESS UNILATERAL 10 0.0007
302 STATUS EPILEPTICUS 8 0.0007
303 DIABETIC FOOT INFECTION 1 0.0007
304 AUDITORY DISORDER 1 0.0007
305 PURULENT DISCHARGE 3 0.0007
306 PRODUCT CONTAINER ISSUE 6 0.0007
307 ABNORMAL SENSATION IN EYE 3 0.0007
308 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
309 BILIARY DILATATION 1 0.0007
310 COCCYDYNIA 1 0.0007
311 PSYCHIATRIC SYMPTOM 5 0.0007
312 GASTROINTESTINAL WALL THICKENING 1 0.0007
313 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
314 EYE OPERATION 3 0.0007
315 CONJUNCTIVITIS 12 0.0006
316 DEFORMITY 6 0.0006
317 BLINDNESS 26 0.0006
318 PRODUCT USE COMPLAINT 10 0.0006
319 BRAIN OEDEMA 8 0.0006
320 GLAUCOMA 12 0.0006
321 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
322 LYMPHOCYTE COUNT INCREASED 2 0.0006
323 EYELID PTOSIS 6 0.0006
324 EYE MOVEMENT DISORDER 4 0.0006
325 DRY EYE 29 0.0006
326 TRISMUS 3 0.0006
327 VARICOSE VEIN 3 0.0006
328 BLOOD CHLORIDE INCREASED 1 0.0006
329 FOETAL DEATH 3 0.0006
330 PERIORBITAL OEDEMA 3 0.0006
331 GRANULOMA 2 0.0006
332 AORTIC STENOSIS 2 0.0006
333 CAROTID ARTERY STENOSIS 2 0.0006
334 BREAST DISCHARGE 1 0.0006
335 EMOTIONAL POVERTY 1 0.0006
336 FACIAL BONES FRACTURE 2 0.0006
337 ASTHENOPIA 3 0.0005
338 MYDRIASIS 7 0.0005
339 CALCIPHYLAXIS 1 0.0005
340 TINNITUS 25 0.0005
341 BLINDNESS TRANSIENT 4 0.0005
342 RETINOPATHY 2 0.0005
343 BONE DENSITY ABNORMAL 2 0.0005
344 CANDIDA INFECTION 9 0.0005
345 PERIORBITAL SWELLING 3 0.0005
346 BILE DUCT OBSTRUCTION 1 0.0005
347 CLAVICLE FRACTURE 2 0.0005
348 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
349 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
350 VISION BLURRED 70 0.0005
351 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
352 DIPLEGIA 1 0.0005
353 PLEURISY 3 0.0005
354 CEREBRAL ATROPHY 2 0.0005
355 TRIGEMINAL NEURALGIA 2 0.0005
356 PERIPHERAL VENOUS DISEASE 2 0.0005
357 BODY TEMPERATURE FLUCTUATION 1 0.0005
358 EOSINOPHIL COUNT INCREASED 4 0.0005
359 DERMATITIS 10 0.0005
360 MUSCLE ATROPHY 6 0.0005
361 INTERVERTEBRAL DISC DISORDER 2 0.0005
362 EXOPHTHALMOS 1 0.0005
363 EAR PAIN 9 0.0005
364 EXPOSED BONE IN JAW 1 0.0005
365 BLOOD CALCIUM INCREASED 4 0.0005
366 SPINAL OSTEOARTHRITIS 4 0.0005
367 WRONG DRUG ADMINISTERED 4 0.0004
368 FACIAL PAIN 4 0.0004
369 CHRONIC GASTRITIS 1 0.0004
370 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
371 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
372 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
373 HAEMOGLOBIN INCREASED 2 0.0004
374 DYSPAREUNIA 2 0.0004
375 RETINAL DETACHMENT 4 0.0004
376 INCREASED TENDENCY TO BRUISE 4 0.0004
377 NEPHROGENIC ANAEMIA 2 0.0004
378 ROSACEA 2 0.0004
379 EYE DISORDER 14 0.0004
380 SKIN ABRASION 2 0.0004
381 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
382 VISUAL IMPAIRMENT 52 0.0004
383 MACULAR DEGENERATION 5 0.0004
384 VISUAL FIELD DEFECT 3 0.0004
385 HUMERUS FRACTURE 2 0.0004
386 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
387 CIRCULATORY COLLAPSE 7 0.0004
388 BREATH ODOUR 1 0.0004
389 EYE OEDEMA 1 0.0004
390 VITREOUS FLOATERS 4 0.0004
391 STAPHYLOCOCCAL SEPSIS 2 0.0004
392 ABDOMINAL TENDERNESS 2 0.0004
393 ECONOMIC PROBLEM 6 0.0004
394 DRY THROAT 4 0.0004
395 DISCOMFORT 24 0.0004
396 CANCER PAIN 1 0.0004
397 NEUTROPHIL COUNT INCREASED 4 0.0004
398 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
399 CATHETER SITE PAIN 1 0.0004
400 TONSILLITIS 2 0.0004
401 NASAL DISCOMFORT 3 0.0004
402 ANORECTAL DISCOMFORT 2 0.0004
403 ANAL ABSCESS 2 0.0004
404 DECUBITUS ULCER 3 0.0004
405 BLOOD PHOSPHORUS INCREASED 1 0.0004
406 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
407 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
408 DERMATITIS CONTACT 4 0.0004
409 FIBULA FRACTURE 1 0.0003
410 COMA SCALE ABNORMAL 1 0.0003
411 HAEMOTHORAX 1 0.0003
412 ACUTE MYOCARDIAL INFARCTION 10 0.0003
413 CARDIOMYOPATHY 5 0.0003
414 DIABETIC FOOT 1 0.0003
415 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
416 FIBROSIS 1 0.0003
417 PERSONALITY CHANGE 3 0.0003
418 EYELIDS PRURITUS 1 0.0003
419 SECRETION DISCHARGE 4 0.0003
420 CATARACT 19 0.0003
421 BLEPHAROSPASM 2 0.0003
422 FOREIGN BODY IN THROAT 1 0.0003
423 BILE DUCT STONE 1 0.0003
424 SCREAMING 2 0.0003
425 DIPLOPIA 8 0.0003
426 BLOOD POTASSIUM INCREASED 5 0.0003
427 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
428 HERPES SIMPLEX 2 0.0003
429 VITAMIN D DEFICIENCY 3 0.0003
430 FACET JOINT SYNDROME 1 0.0003
431 DISABILITY 6 0.0003
432 SINUS DISORDER 6 0.0003
433 ADVERSE REACTION 4 0.0003
434 CYTOLYTIC HEPATITIS 1 0.0003
435 EYE HAEMORRHAGE 4 0.0003
436 SKIN MASS 2 0.0003
437 BRAIN INJURY 3 0.0003
438 BLOOD UREA INCREASED 5 0.0003
439 PRODUCT ADMINISTRATION ERROR 6 0.0003
440 PRODUCT TASTE ABNORMAL 4 0.0003
441 PRODUCT LABEL ISSUE 2 0.0003
442 DIABETIC RETINOPATHY 1 0.0003
443 BRONCHOPNEUMONIA 1 0.0003
444 SWELLING FACE 19 0.0003
445 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
446 FOLLICULITIS 3 0.0003
447 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
448 HEAD DISCOMFORT 5 0.0003
449 FIBRIN D DIMER INCREASED 1 0.0003
450 RETINAL HAEMORRHAGE 2 0.0003
451 THIRST 5 0.0003
452 LIVER FUNCTION TEST INCREASED 6 0.0003
453 BONE LESION 1 0.0003
454 TONGUE DISORDER 2 0.0003
455 DEVICE KINK 1 0.0003
456 END STAGE RENAL DISEASE 5 0.0003
457 AMYLASE INCREASED 1 0.0003
458 CHRONIC SINUSITIS 1 0.0003
459 AUTOIMMUNE THYROIDITIS 1 0.0003
460 EAR INFECTION 7 0.0003
461 SCAB 3 0.0003
462 DRUG DISPENSING ERROR 4 0.0003
463 LIPASE INCREASED 2 0.0003
464 POST PROCEDURAL COMPLICATION 5 0.0003
465 MADAROSIS 3 0.0003
466 SKIN LESION 7 0.0003
467 MULTIPLE ALLERGIES 2 0.0003
468 PNEUMOTHORAX 4 0.0003
469 OBESITY 4 0.0003
470 HYPERLIPIDAEMIA 3 0.0003
471 ABSCESS 4 0.0003
472 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
473 SENSORY LOSS 2 0.0002
474 NOCTURIA 3 0.0002
475 NO THERAPEUTIC RESPONSE 3 0.0002
476 GOITRE 1 0.0002
477 CARDIOMEGALY 3 0.0002
478 EXTRAVASATION 1 0.0002
479 ANAPHYLACTOID REACTION 1 0.0002
480 SKIN DISORDER 8 0.0002
481 DYSPNOEA EXERTIONAL 9 0.0002
482 DERMATITIS ALLERGIC 3 0.0002
483 SENSATION OF FOREIGN BODY 2 0.0002
484 AORTIC VALVE INCOMPETENCE 1 0.0002
485 VITAMIN D DECREASED 2 0.0002
486 HIATUS HERNIA 3 0.0002
487 HYPONATRAEMIA 13 0.0002
488 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
489 DEAFNESS 6 0.0002
490 LOCAL SWELLING 4 0.0002
491 DIVERTICULUM INTESTINAL 1 0.0002
492 GRIP STRENGTH DECREASED 2 0.0002
493 SARS-COV-2 TEST POSITIVE 3 0.0002
494 GINGIVAL SWELLING 1 0.0002
495 ABDOMINAL ABSCESS 1 0.0002
496 LEUKOCYTOSIS 4 0.0002
497 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
498 RESPIRATORY FAILURE 16 0.0002
499 PERICARDIAL EFFUSION 5 0.0002
500 HEPATIC STEATOSIS 4 0.0002
501 GASTRITIS EROSIVE 1 0.0002
502 FEELING OF DESPAIR 1 0.0002
503 HEPATOCELLULAR INJURY 3 0.0002
504 PRODUCT PACKAGING ISSUE 2 0.0002
505 BRONCHOSPASM 3 0.0002
506 ENTEROCOCCAL INFECTION 1 0.0002
507 SINUS BRADYCARDIA 2 0.0002
508 MENTAL IMPAIRMENT 5 0.0002
509 RENAL TUBULAR NECROSIS 2 0.0002
510 HOSPICE CARE 2 0.0002
511 EMBEDDED DEVICE 2 0.0002
512 BLADDER DISORDER 2 0.0002
513 HYPOXIA 7 0.0002
514 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
515 DYSLIPIDAEMIA 1 0.0002
516 FEMORAL NECK FRACTURE 1 0.0002
517 ENDOCARDITIS 1 0.0002
518 INITIAL INSOMNIA 2 0.0002
519 CACHEXIA 1 0.0002
520 TEMPERATURE INTOLERANCE 2 0.0002
521 ACUTE MYELOID LEUKAEMIA 3 0.0002
522 HYPERGLYCAEMIA 7 0.0002
523 TENDERNESS 2 0.0002
524 JOINT STIFFNESS 5 0.0002
525 BREAST PAIN 2 0.0002
526 COMPRESSION FRACTURE 1 0.0002
527 MUSCLE TIGHTNESS 3 0.0002
528 PRURITUS GENERALISED 4 0.0002
529 INJURY 13 0.0002
530 PULMONARY THROMBOSIS 2 0.0002
531 DRUG INTERACTION 29 0.0002
532 GASTROINTESTINAL PAIN 2 0.0002
533 PHOTOSENSITIVITY REACTION 3 0.0002
534 DEAFNESS UNILATERAL 1 0.0002
535 CHOKING SENSATION 1 0.0002
536 DENTAL CARIES 2 0.0002
537 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
538 MENTAL STATUS CHANGES 5 0.0002
539 IMPAIRED DRIVING ABILITY 2 0.0002
540 PRODUCT AVAILABILITY ISSUE 4 0.0002
541 HERPES VIRUS INFECTION 1 0.0002
542 EMOTIONAL DISTRESS 21 0.0002
543 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
544 HYPERSENSITIVITY 32 0.0002
545 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
546 LYMPHOCYTE COUNT DECREASED 3 0.0002
547 DECREASED INTEREST 1 0.0002
548 BRADYKINESIA 1 0.0002
549 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
550 CATARACT OPERATION 1 0.0002
551 CHOLECYSTITIS 2 0.0002
552 HEPATITIS B 1 0.0002
553 OSTEOMYELITIS 3 0.0002
554 ADRENAL INSUFFICIENCY 2 0.0002
555 ABNORMAL WEIGHT GAIN 2 0.0002
556 GENERALISED OEDEMA 2 0.0002
557 SWOLLEN TONGUE 5 0.0002
558 LIVER DISORDER 7 0.0002
559 FLUID RETENTION 8 0.0002
560 SLEEP APNOEA SYNDROME 3 0.0002
561 INFUSION SITE PAIN 2 0.0002
562 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
563 PRODUCT QUALITY ISSUE 21 0.0002
564 ANGINA UNSTABLE 1 0.0002
565 ASPERGILLUS INFECTION 1 0.0002
566 HAEMATOCRIT DECREASED 3 0.0002
567 APPETITE DISORDER 1 0.0002
568 JOINT RANGE OF MOTION DECREASED 2 0.0001
569 BRONCHIECTASIS 1 0.0001
570 SINUS CONGESTION 2 0.0001
571 TASTE DISORDER 3 0.0001
572 BLOOD TESTOSTERONE DECREASED 1 0.0001
573 PERITONITIS 3 0.0001
574 TREATMENT FAILURE 12 0.0001
575 MASS 2 0.0001
576 CARPAL TUNNEL SYNDROME 2 0.0001
577 DEVICE OCCLUSION 2 0.0001
578 SUICIDAL IDEATION 13 0.0001
579 SEASONAL ALLERGY 2 0.0001
580 LYMPHADENOPATHY 5 0.0001
581 HAND FRACTURE 1 0.0001
582 OROPHARYNGEAL PAIN 13 0.0001
583 CONVULSION 8 0.0001
584 SUBDURAL HAEMATOMA 2 0.0001
585 POOR QUALITY SLEEP 3 0.0001
586 RHINORRHOEA 9 0.0001
587 PRODUCT DISPENSING ERROR 3 0.0001
588 CRYING 5 0.0001
589 FLUID OVERLOAD 2 0.0001
590 APATHY 2 0.0001
591 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
592 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
593 FEELING DRUNK 1 0.0001
594 DUODENAL ULCER PERFORATION 1 0.0001
595 PULMONARY MASS 2 0.0001
596 PULMONARY OEDEMA 6 0.0001
597 BLOOD COUNT ABNORMAL 2 0.0001
598 CHRONIC KIDNEY DISEASE 10 0.0001
599 HEPATOCELLULAR CARCINOMA 1 0.0001
600 SKIN DISCOLOURATION 6 0.0001
601 EMOTIONAL DISORDER 4 0.0001
602 HAEMOLYSIS 1 0.0001
603 ANKLE FRACTURE 2 0.0001
604 TENDONITIS 2 0.0001
605 APHTHOUS ULCER 1 0.0001
606 APNOEA 1 0.0001
607 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
608 BASAL CELL CARCINOMA 2 0.0001
609 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
610 DRY SKIN 17 0.0001
611 AFFECTIVE DISORDER 1 0.0001
612 HEAD INJURY 4 0.0001
613 BLOOD ALBUMIN DECREASED 1 0.0001
614 PRODUCT PRESCRIBING ERROR 3 0.0001
615 RESPIRATORY TRACT CONGESTION 2 0.0001
616 GINGIVAL PAIN 1 0.0001
617 HYPOTHYROIDISM 4 0.0001
618 BLOOD DISORDER 1 0.0001
619 CHEST PAIN 23 0.0001
620 NIGHT SWEATS 4 0.0001
621 FRUSTRATION TOLERANCE DECREASED 1 0.0001
622 NEURALGIA 3 0.0001
623 BACK DISORDER 2 0.0001
624 ANXIETY 35 0.0001
625 AMNESIA 8 0.0001
626 ABNORMAL FAECES 1 0.0001
627 CONDITION AGGRAVATED 37 0.0001
628 FACE OEDEMA 2 0.0001
629 SKIN EXFOLIATION 10 0.0001
630 SCAR 2 0.0001
631 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
632 CARDIAC OPERATION 1 0.0001
633 ANURIA 1 0.0001
634 HAEMATOMA 3 0.0001
635 NIGHTMARE 4 0.0001
636 CARDIAC MURMUR 1 0.0001
637 MIGRAINE 11 0.0001
638 VERTIGO 7 0.0001
639 MUSCLE SPASMS 21 0.0001
640 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
641 CARDIOTOXICITY 1 0.0001
642 THROAT IRRITATION 5 0.0001
643 SYNOVITIS 2 0.0001
644 TOOTHACHE 2 0.0001
645 NEPHROLITHIASIS 5 0.0001
646 DYSURIA 4 0.0001
647 BLOOD GLUCOSE ABNORMAL 2 0.0001
648 DIARRHOEA HAEMORRHAGIC 1 0.0001
649 SWELLING 10 0.0001
650 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
651 FLANK PAIN 1 0.0001
652 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
653 ARTERIOSCLEROSIS 1 0.0001
654 ARRHYTHMIA 5 0.0001
655 GASTRIC ULCER 2 0.0001
656 ANGINA PECTORIS 3 0.0001
657 PERIPHERAL SWELLING 16 0.0001
658 ATELECTASIS 1 0.0001
659 PRESCRIBED OVERDOSE 2 0.0001
660 DIZZINESS POSTURAL 1 0.0001
661 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
662 HAEMORRHOIDS 2 0.0001
663 PLASMA CELL MYELOMA 4 0.0001
664 BONE PAIN 6 0.0001
665 LABORATORY TEST ABNORMAL 3 0.0001
666 BODY TEMPERATURE DECREASED 1 0.0001
667 WHEEZING 6 0.0001
668 BURNING SENSATION 7 0.0001
669 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
670 EMPHYSEMA 1 0.0001
671 INTENTIONAL SELF-INJURY 2 0.0001
672 THERAPY INTERRUPTED 7 0.0001
673 FEELING HOT 6 0.0001
674 CHEST DISCOMFORT 10 0.0001
675 MUSCULAR WEAKNESS 11 0.0001
676 PULMONARY HYPERTENSION 2 0.0001
677 MOUTH ULCERATION 2 0.0001
678 HYPERTENSION 20 0.0001
679 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
680 CYSTITIS 3 0.0001
681 EATING DISORDER 2 0.0001
682 IMPAIRED WORK ABILITY 2 0.0001
683 HYPOAESTHESIA 14 0.0001
684 HYPOACUSIS 4 0.0001
685 DECREASED ACTIVITY 1 0.0001
686 BALANCE DISORDER 8 0.0001
687 ATRIAL FIBRILLATION 9 0.0001
688 OEDEMA 5 0.0001
689 BLOOD CREATININE INCREASED 6 0.0001
690 ASPIRATION 1 0.0001
691 COVID-19 16 0.0001
692 SEPSIS 10 0.0001
693 ANGER 3 0.0001
694 CHOLECYSTECTOMY 1 0.0001
695 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
696 LETHARGY 5 0.0001
697 SEIZURE 10 0.0001
698 DRY MOUTH 7 0.0001
699 ABDOMINAL DISTENSION 9 0.0001
700 HYPERKALAEMIA 3 0.0001
701 ACUTE KIDNEY INJURY 13 0.0001
702 COVID-19 PNEUMONIA 1 0.0001
703 PAIN 52 0.0001
704 TREMOR 14 0.0001
705 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
706 BLOOD IRON DECREASED 1 0.0001
707 PULMONARY EMBOLISM 8 0.0001
708 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
709 LOCALISED INFECTION 2 0.0001
710 URINARY TRACT INFECTION 14 0.0001
711 OEDEMA PERIPHERAL 10 0.0001
712 ACCIDENTAL OVERDOSE 3 0.0001
713 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
714 BRONCHITIS 6 0.0001
715 OSTEONECROSIS OF JAW 2 0.0001
716 CYST 1 0.0001
717 PNEUMONIA ASPIRATION 2 0.0001
718 HOT FLUSH 6 0.0001
719 CELLULITIS 4 0.0001
720 COUGH 22 0.0001
721 URTICARIA 13 0.0001
722 RESPIRATORY TRACT INFECTION 2 0.0001
723 GASTRITIS 2 0.0001
724 ADVERSE EVENT 7 0.0001
725 PANCREATITIS 4 0.0001
726 DYSMENORRHOEA 1 0.0001
727 RENAL FAILURE 10 0.0001
728 BLOOD PRESSURE DECREASED 5 0.0001
729 HAIR TEXTURE ABNORMAL 1 0.0001
730 BLOOD GLUCOSE INCREASED 14 0.0001
731 DYSKINESIA 3 0.0001
732 LIMB INJURY 2 0.0001
733 DRUG TOXICITY 1 0.0001
734 HEADACHE 46 0.0001
735 GINGIVAL BLEEDING 1 0.0001
736 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
737 INFLUENZA 8 0.0001
738 ROAD TRAFFIC ACCIDENT 3 0.0001
739 COORDINATION ABNORMAL 1 0.0001
740 APHONIA 1 0.0001
741 NECK PAIN 4 0.0001
742 WOUND 2 0.0001
743 PRODUCT DOSE OMISSION ISSUE 21 0.0001
744 SLEEP DISORDER 5 0.0001
745 PAIN IN JAW 2 0.0001
746 DIALYSIS 1 0.0001
747 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
748 RED BLOOD CELL COUNT DECREASED 2 0.0001
749 PARAESTHESIA 11 0.0001
750 DEVICE DISLOCATION 3 0.0001
751 DYSPNOEA 39 0.0001
752 MYOCARDIAL INFARCTION 12 0.0001
753 LIVER FUNCTION TEST ABNORMAL 2 0.0001
754 GASTROENTERITIS 1 0.0001
755 DYSPHONIA 4 0.0001
756 HAEMOGLOBIN DECREASED 7 0.0001
757 DIZZINESS 34 0.0001
758 ERYTHEMA 14 0.0001
759 AGITATION 5 0.0001
760 ANGIOEDEMA 3 0.0001
761 PRURITUS 26 0.0001
762 HAEMORRHAGE INTRACRANIAL 1 0.0001
763 THERAPY NON-RESPONDER 3 0.0001
764 BONE LOSS 1 0.0001
765 OFF LABEL USE 58 0.0001
766 ALOPECIA 13 0.0001
767 FALL 22 0.0001
768 UNEVALUABLE EVENT 5 0.0001
769 CORONARY ARTERY DISEASE 2 0.0001
770 ACNE 5 0.0001
771 ILL-DEFINED DISORDER 4 0.0001
772 BLOOD PRESSURE INCREASED 10 0.0001
773 HYPOKALAEMIA 3 0.0001
774 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
775 PNEUMONIA 21 0.0001
776 FEMUR FRACTURE 2 0.0001
777 BLOOD CHOLESTEROL INCREASED 3 0.0001
778 RASH 28 0.0001
779 PRODUCTIVE COUGH 3 0.0001
780 MOOD SWINGS 2 0.0001
781 THROMBOCYTOPENIA 7 0.0001
782 BLOOD GLUCOSE DECREASED 3 0.0001
783 MOVEMENT DISORDER 2 0.0001
784 CARDIAC FAILURE 5 0.0001
785 HIP FRACTURE 2 0.0001
786 LUNG DISORDER 3 0.0001
787 STAPHYLOCOCCAL INFECTION 2 0.0001
788 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
789 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
790 BACK PAIN 14 0.0001
791 COAGULOPATHY 1 0.0001
792 DEHYDRATION 8 0.0001
793 SYNCOPE 6 0.0001
794 AGGRESSION 3 0.0001
795 URINARY RETENTION 2 0.0001
796 CONSTIPATION 13 0.0001
797 TYPE 2 DIABETES MELLITUS 2 0.0001
798 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
799 HEMIPARESIS 1 0.0001
800 PRODUCT USE ISSUE 11 0.0001
801 HAEMATURIA 2 0.0001
802 GASTRIC DISORDER 2 0.0001
803 VOMITING 27 0.0001
804 EOSINOPHILIA 1 0.0001
805 MALAISE 25 0.0001
806 HEART RATE DECREASED 2 0.0001
807 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
808 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
809 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
810 INSOMNIA 15 0.0001
811 TACHYCARDIA 5 0.0001
812 GALLBLADDER DISORDER 1 0.0001
813 SKIN BURNING SENSATION 4 0.0001
814 DEVICE ISSUE 5 0.0001
815 GOUT 1 0.0001
816 GASTROENTERITIS VIRAL 1 0.0001
817 BONE DISORDER 1 0.0001
818 NASOPHARYNGITIS 10 0.0001
819 FATIGUE 42 0.0001
820 EPISTAXIS 4 0.0001
821 OXYGEN SATURATION DECREASED 3 0.0001
822 TOXICITY TO VARIOUS AGENTS 9 0.0001
823 ASTHMA 6 0.0001
824 HALLUCINATION 4 0.0001
825 INTESTINAL OBSTRUCTION 2 0.0001
826 BLOOD SODIUM DECREASED 1 0.0001
827 FOOT FRACTURE 1 0.0001
828 DEPRESSION 12 0.0001
829 FEELING JITTERY 1 0.0001
830 DIABETES MELLITUS 4 0.0001
831 ACUTE RESPIRATORY FAILURE 1 0.0001
832 HERNIA 1 0.0001
833 ERUCTATION 1 0.0001
834 CHILLS 6 0.0001
835 ARTHRITIS 4 0.0001
836 ABNORMAL BEHAVIOUR 2 0.0001
837 DISORIENTATION 2 0.0001
838 HEART RATE INCREASED 5 0.0001
839 BLOOD PRESSURE ABNORMAL 1 0.0001
840 COMPLICATION OF DEVICE INSERTION 1 0.0001
841 CARDIAC FAILURE CONGESTIVE 4 0.0000
842 FULL BLOOD COUNT DECREASED 1 0.0000
843 FEEDING DISORDER 1 0.0000
844 PLEURAL EFFUSION 3 0.0000
845 NEUTROPHIL COUNT DECREASED 2 0.0000
846 BODY TEMPERATURE INCREASED 1 0.0000
847 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
848 SINUSITIS 5 0.0000
849 OSTEOPOROSIS 2 0.0000
850 ILLNESS 5 0.0000
851 ARTHRALGIA 20 0.0000
852 DIARRHOEA 31 0.0000
853 CARDIO-RESPIRATORY ARREST 2 0.0000
854 CEREBROVASCULAR ACCIDENT 8 0.0000
855 OSTEOARTHRITIS 2 0.0000
856 MYALGIA 8 0.0000
857 WEIGHT DECREASED 13 0.0000
858 DEEP VEIN THROMBOSIS 3 0.0000
859 FAECES DISCOLOURED 1 0.0000
860 MENTAL DISORDER 2 0.0000
861 NAUSEA 36 0.0000
862 APPLICATION SITE PAIN 1 0.0000
863 HEPATOTOXICITY 1 0.0000
864 HYPOTENSION 9 0.0000
865 GASTROINTESTINAL DISORDER 4 0.0000
866 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
867 ADVERSE DRUG REACTION 4 0.0000
868 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
869 HEART RATE IRREGULAR 1 0.0000
870 APPLICATION SITE PRURITUS 1 0.0000
871 DECREASED APPETITE 10 0.0000
872 ABDOMINAL PAIN 10 0.0000
873 COGNITIVE DISORDER 2 0.0000
874 DISEASE PROGRESSION 5 0.0000
875 NEUROPATHY PERIPHERAL 4 0.0000
876 RASH ERYTHEMATOUS 2 0.0000
877 BLOOD PRESSURE FLUCTUATION 1 0.0000
878 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
879 CONTUSION 4 0.0000
880 DRUG INTOLERANCE 4 0.0000
881 FIBROMYALGIA 1 0.0000
882 PAIN IN EXTREMITY 12 0.0000
883 ENCEPHALOPATHY 1 0.0000
884 ABASIA 1 0.0000
885 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
886 ASTHENIA 15 0.0000
887 HAEMATEMESIS 1 0.0000
888 HEPATITIS 1 0.0000
889 LOSS OF CONSCIOUSNESS 5 0.0000
890 ERECTILE DYSFUNCTION 1 0.0000
891 HYPERHIDROSIS 5 0.0000
892 INFLAMMATION 2 0.0000
893 NO ADVERSE EVENT 7 0.0000
894 EXPOSURE VIA SKIN CONTACT 1 0.0000
895 ECZEMA 2 0.0000
896 SPEECH DISORDER 2 0.0000
897 DEPRESSED MOOD 2 0.0000
898 BRADYCARDIA 2 0.0000
899 PYREXIA 13 0.0000
900 INJECTION SITE HAEMORRHAGE 3 0.0000
901 DISTURBANCE IN ATTENTION 2 0.0000
902 BLOOD BILIRUBIN INCREASED 1 0.0000
903 RASH PRURITIC 2 0.0000
904 ANAEMIA 7 0.0000
905 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
906 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
907 DRUG INEFFECTIVE 48 0.0000
908 CARDIAC ARREST 3 0.0000
909 ABNORMAL DREAMS 1 0.0000
910 ANAPHYLACTIC REACTION 2 0.0000
911 DIVERTICULITIS 1 0.0000
912 HAEMOPTYSIS 1 0.0000
913 DEMENTIA 1 0.0000
914 ABDOMINAL DISCOMFORT 6 0.0000
915 RENAL IMPAIRMENT 3 0.0000
916 FLATULENCE 2 0.0000
917 INCORRECT DOSE ADMINISTERED 8 0.0000
918 HERPES ZOSTER 2 0.0000
919 SOMNOLENCE 7 0.0000
920 PRODUCT SUBSTITUTION ISSUE 2 0.0000
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
922 PRODUCT STORAGE ERROR 3 0.0000
923 DYSSTASIA 1 0.0000
924 MUSCULOSKELETAL STIFFNESS 3 0.0000
925 PALPITATIONS 4 0.0000
926 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
927 NASAL CONGESTION 2 0.0000
928 ASCITES 1 0.0000
929 ABDOMINAL PAIN UPPER 7 0.0000
930 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
931 FEELING ABNORMAL 8 0.0000
932 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
933 IRRITABILITY 2 0.0000
934 BLOOD POTASSIUM DECREASED 1 0.0000
935 EPILEPSY 1 0.0000
936 CARDIAC DISORDER 3 0.0000
937 CONFUSIONAL STATE 5 0.0000
938 CHOLELITHIASIS 1 0.0000
939 DYSPEPSIA 3 0.0000
940 EXPIRED PRODUCT ADMINISTERED 1 0.0000
941 FUNGAL INFECTION 1 0.0000
942 GAIT INABILITY 1 0.0000
943 NEUTROPENIA 4 0.0000
944 DELIRIUM 1 0.0000
945 DEVICE USE ERROR 1 0.0000
946 HAEMORRHAGE 3 0.0000
947 C-REACTIVE PROTEIN INCREASED 1 0.0000
948 DYSGEUSIA 2 0.0000
949 DYSARTHRIA 1 0.0000
950 RHEUMATOID ARTHRITIS 3 0.0000
951 COLITIS 1 0.0000
952 GAIT DISTURBANCE 5 0.0000
953 INJECTION SITE SWELLING 2 0.0000
954 HOSPITALISATION 4 0.0000
955 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
956 INJECTION SITE BRUISING 2 0.0000
957 THROMBOSIS 2 0.0000
958 DEVICE BREAKAGE 1 0.0000
959 DEVICE LEAKAGE 1 0.0000
960 INTENTIONAL PRODUCT MISUSE 2 0.0000
961 COLITIS ULCERATIVE 1 0.0000
962 WEIGHT INCREASED 5 0.0000
963 MEMORY IMPAIRMENT 3 0.0000
964 DYSPHAGIA 2 0.0000
965 COMA 1 0.0000
966 DEATH 17 0.0000
967 FLUSHING 2 0.0000
968 INJECTION SITE PAIN 6 0.0000
969 DERMATITIS ATOPIC 1 0.0000
970 DRUG EFFECT DECREASED 1 0.0000
971 OVERDOSE 4 0.0000
972 HAEMATOCHEZIA 1 0.0000
973 BLISTER 1 0.0000
974 JOINT SWELLING 2 0.0000
975 PSORIASIS 2 0.0000
976 FEBRILE NEUTROPENIA 1 0.0000
977 HEPATIC ENZYME INCREASED 1 0.0000
978 DEVICE MALFUNCTION 1 0.0000
979 INFECTION 2 0.0000
980 DRUG DEPENDENCE 2 0.0000
981 DRUG ABUSE 1 0.0000
982 BREAST CANCER 1 0.0000
983 DRUG DOSE OMISSION 1 0.0000